Fette Compacting and CMIC CMO USA have announced a new partnership focused on pharmaceutical manufacturing technology. The collaboration involves integrating Fette Compacting’s FE CPS Continuous Direct Compression system and the FE55 rotary tablet press into CMIC’s GMP-certified cleanrooms in Cranbury, New Jersey. This setup is intended to enable pharmaceutical companies to develop, validate, and produce clinical samples for continuous manufacturing processes under regulated conditions.
The partnership brings together Fette Compacting’s expertise in process engineering and tableting with CMIC’s experience in GMP-compliant development and production of clinical and commercial pharmaceutical products. The combined platform will allow pharmaceutical manufacturers to conduct formulation development, process parameter testing, and analytical studies in a single location. Technologies such as Fette Compacting’s F Lab series and embedded process analysis technology (ePAT) are included, supporting real-time monitoring and precise characterization of powder and tablet properties.
Both companies indicate that this collaboration is designed to streamline the development and validation of oral solid dosage forms, potentially accelerating the process of bringing new medicines to market. The new development platform will be introduced to industry professionals at an event in June 2025, with plans for further expansion of services in the future.